Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
BD Diagnostic Systems is a major business segment of Becton, Dickinson and Company (BD) that focuses on providing integrated systems for the safe collection and transport of diagnostic specimens, as well as instruments and reagents for the detection of infectious diseases and cancers. The company is a global leader in automated microbiology, offering platforms for blood culture, identification and susceptibility testing, and molecular diagnostics. Their product portfolio includes the BD BACTEC blood culture systems, the BD MAX molecular platform, and the BD Phoenix automated microbiology system. By streamlining laboratory workflows and providing rapid, accurate results, BD Diagnostic Systems plays a critical role in improving patient management and combating antimicrobial resistance.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Diagnostic Systems.